Early detection and prediction of cardiotoxicity in chemotherapy-treated patients - Wikidata - awgldk - TriplyDB

Early detection and prediction of cardiotoxicity in chemotherapy-treated patients

Early detection and prediction of cardiotoxicity in chemotherapy-treated patients

http://www.wikidata.org/entity/Q36988282

about

Heart failure in chemotherapy-related cardiomyopathy: Can exercise make a difference?The Role of Biomarkers in Decreasing Risk of Cardiac Toxicity after Cancer Therapy Pathophysiology and preventive strategies of anthracycline-induced cardiotoxicity Recent advances in echocardiography: strain and strain rate imaging Exercise Prevention of Cardiovascular Disease in Breast Cancer Survivors Cardiac toxicity in cancer survivors Serum biomarkers for the detection of cardiac toxicity after chemotherapy and radiation therapy in breast cancer patients Noninvasive imaging of cardiovascular injury related to the treatment of cancer Use of biomarkers for the assessment of chemotherapy-induced cardiac toxicity.Cardiac risk in the treatment of breast cancer: assessment and management.Recent Advances on Pathophysiology, Diagnostic and Therapeutic Insights in Cardiac Dysfunction Induced by Antineoplastic Drugs Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section BNP predicts chemotherapy-related cardiotoxicity and death: comparison with gated equilibrium radionuclide ventriculography Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.Subclinical ventricular dysfunction detected by speckle tracking two years after use of anthracycline.Cardiac complications of chemotherapy: role of imaging.Intersection of cardiology and oncology clinical practices.Cardiac imaging approaches to evaluate drug-induced myocardial dysfunction Assessing the Cardiac Toxicity of Chemotherapeutic Agents: Role of Echocardiography.Open access integrated therapeutic and diagnostic platforms for personalized cardiovascular medicine Screening mammography--early detection or over-diagnosis? Contribution from Australian data.Diagnostic Strategies for Early Recognition of Cancer Therapeutics-Related Cardiac Dysfunction.Cardiac mechanics evaluated by speckle tracking echocardiography.Anthracycline induced cardiotoxicity: biomarkers and "Omics" technology in the era of patient specific care.Trastuzumab Administration in Patients with Metastatic Breast Cancer - Experience of a Large University Breast Center Creating a Biomarker Panel for Early Detection of Chemotherapy Related Cardiac Dysfunction in Breast Cancer Patients A phase 2 randomized trial to evaluate the impact of a supervised exercise program on cardiotoxicity at 3 months in patients with HER2 overexpressing breast cancer undergoing adjuvant treatment by trastuzumab: design of the CARDAPAC study.Chemotherapy-induced cardiotoxicity.High-sensitivity troponin T as a marker to predict cardiotoxicity in breast cancer patients with adjuvant trastuzumab therapy.Cancer and cardiovascular disease: the use of novel echocardiography measures to predict subsequent cardiotoxicity in breast cancer treated with anthracyclines and trastuzumab Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab An inhibitor of the δPKC interaction with the d subunit of F1Fo ATP synthase reduces cardiac troponin I release from ischemic rat hearts: utility of a novel ammonium sulfate precipitation technique Trastuzumab-induced cardiac dysfunction: A 'dual-hit'Managing chemotherapy-related cardiotoxicity in survivors of childhood cancers.Utilizing cardiac biomarkers to detect and prevent chemotherapy-induced cardiomyopathy.Association of peripheral nerve conduction in diabetic neuropathy with subclinical left ventricular systolic dysfunction.Serial measurements of NT-proBNP are predictive of not-high-dose anthracycline cardiotoxicity in breast cancer patients.Troponin T-release associates with cardiac radiation doses during adjuvant left-sided breast cancer radiotherapy.Utility of 3-dimensional echocardiography, global longitudinal strain, and exercise stress echocardiography to detect cardiac dysfunction in breast cancer patients treated with doxorubicin-containing adjuvant therapy.Doxorubicin-induced cardiomyopathy 17 years after chemotherapy

P2860

Q26740352-EEC04A62-52B9-4312-8D3A-F7F2AE07ABAF Q26743433-D5CFFA03-04FB-408A-958D-BCE8E3FF4C7C Q26744675-6B82130A-9CE9-48E8-8EBF-2C0D083B2D19 Q26751196-2C6B3F1E-BEBB-467C-A855-277984B41B79 Q26785410-DB23752D-C491-40CE-98AF-C88AF69730B5 Q26851957-42C62D47-ECD5-4126-9FC9-903E12E85C89 Q27007849-0EC7E1E8-5824-4E89-BF75-78427B6583DA Q27024715-287FA01C-C540-4A3E-99F8-B3136F8517F3 Q27027354-B6F5FE17-30B5-421D-B4C9-09022CFC99A8 Q28081385-EDA25236-5B99-4B41-B881-E289546EAC6E Q28087776-A52812C3-9029-4999-97B1-BF749A412ECF Q28269814-5FA22944-64BC-454C-BDC1-B7B4C3632571 Q28538548-80FF9BF9-ABEB-49D8-B434-7F68D07A6D12 Q30401812-6C9F59BB-67E5-4064-80A7-EAF8B32C9E54 Q30412756-77461706-C0ED-4EE2-98B4-EF150A19DB43 Q30415201-9728AFEA-D57A-4811-8FE2-25E102A71391 Q30428702-EB4FF955-8E82-4094-B42C-7FBE9AC9F8E9 Q30446453-9EE8BC48-5F1C-4ACC-81CB-0A21A93F3DC7 Q30446509-1C1D1FF1-BF2C-4885-A14E-5CF14D7EA2B2 Q30487537-860B087F-D373-42CA-B1AC-2D8324F2CC06 Q30851278-2C816BBC-2B4E-4056-829F-585585BD4D0D Q33565936-358602FE-72C4-4279-A145-67F611EF12A6 Q33641546-93E26A80-AC35-4D34-B049-F43E8BB828D1 Q33658456-9B398F0B-859F-49A3-B96E-E873C0208269 Q33800955-41C768C9-B52E-45F2-A039-F41D3C1578E9 Q33816471-9126022C-0505-4CFF-8AE9-E3A52AA1A529 Q33823991-FD5FB0F2-15A2-4638-A18D-1EB648BD06EE Q34258080-F71BC13F-C6E1-488D-812A-FDA43BAB7EA1 Q34438850-A9290E0A-22F1-4D73-81DC-D7AC6E461765 Q34474264-777EBD4C-E189-484E-AE66-66462FB2169C Q34855776-152E5254-E4AF-46DF-BC21-16A82B38A7A1 Q34925984-C0191CE3-7F3C-4C60-987F-3CECC5431A60 Q35532125-4A040976-14AB-4BD6-AF31-C60DCD7EE09F Q35562745-C9F123E0-C03B-4002-A329-636DDDC1C408 Q35588736-2EF5B2E0-F55C-4A0D-8AA4-F52151363BCB Q35595644-279E3FAB-ED80-43B3-AA7E-E76B270FF1F2 Q35623306-AC4CCDFD-7A2A-4739-BDA2-AFDD4BE813AF Q35834621-742F010D-D490-41F4-9C32-6C23A3074BC4 Q35905883-C7118DF7-93D3-4CEA-BFAB-0C39D80F64CE Q36011893-23F5AB34-D83C-48DE-B750-615C9DABB4F9

P2860

Early detection and prediction of cardiotoxicity in chemotherapy-treated patients

http://www.wikidata.org/entity/Q36988282

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Early detection and prediction of cardiotoxicity in chemotherapy-treated patients

@en

type

label

Early detection and prediction of cardiotoxicity in chemotherapy-treated patients

@en

prefLabel

Early detection and prediction of cardiotoxicity in chemotherapy-treated patients

@en

P1433

Q36988282-6C90C010-10C9-41CD-B8BE-900EC6C51822

P1476

Q36988282-EEDB99CD-71B8-4C70-B2C6-A78A9BAAE51F

P2093

Q36988282-02CCA124-0BEC-4C31-85B8-8F8821F8429A

Q36988282-05E555CD-4BD3-4DB3-951D-5F3EE4645900

Q36988282-0AAF30F9-79E5-4F64-9127-52F3E38096AB

Q36988282-1C1C5297-E846-4668-BB08-5C8384E09AF5

Q36988282-377E76FB-E9A2-487B-8A5B-9FFED5508D2D

Q36988282-610C4F34-C4D5-4CED-AF2F-62F706F8EAB6

Q36988282-6377201F-D27E-4A17-8307-9454F1EB7CEA

Q36988282-9D66B4AC-8F1A-4C37-B128-7D6DC807631D

Q36988282-9DC4F403-4364-41A1-82D4-48D52451F4E6

Q36988282-B5B75F9B-F3E4-44FD-8036-7519D603578F

P2860

Q36988282-057F768F-3F58-45EE-8F63-FF9DB6CEEC29

Q36988282-1787A48E-2241-4DDA-A306-42221A63338B

Q36988282-18C87B17-D4FC-4353-9454-22F7D511CFE6

Q36988282-3AA7DC98-C97F-49E6-80CB-316879EF53CA

Q36988282-6D787C2D-05D6-4A58-BE2C-2A50B56B3B4C

Q36988282-7F5A547A-DFE6-42B6-B1FB-1DA34F37D644

Q36988282-90CDB11D-FE3F-4A55-9A07-5095EFA24B2E

Q36988282-9F95BF5A-5B79-481E-90E4-DF1F9E174700

Q36988282-A1B2C890-FEF1-4943-B32A-903951AEF4DB

Q36988282-D1C15C94-AABD-431D-B9AF-DEBEDC70A5AC

P304

Q36988282-3703F6D3-253B-4DF2-90D8-F6B958556A6B

P31

Q36988282-94A5A80B-249F-468F-BED5-DE914D0A43D2

P356

Q36988282-A293368A-C253-4BFF-AD48-0C6A99FD69B8

P407

Q36988282-3A349D15-2777-4A6F-A5B5-E182110E716F

P433

Q36988282-59D6E274-34B3-4344-9C95-E04515C39747

P478

Q36988282-C76160BA-D43B-438A-A896-F2C8565680F6

P50

Q36988282-2C743429-EF4B-4768-8F49-C5F465773F0A

P577

Q36988282-E94C6498-C55A-4798-B222-51B1EB74301F

P698

Q36988282-087C6C0B-CE99-401C-ACA0-43D79C9A562D

P921

Q36988282-A154EF5D-D92D-4566-8175-BA1BBBFBE3F5

P932

Q36988282-9DAF7002-6B35-48C1-A8EF-48FE9B594D10

P356

J.AMJCARD.2011.01.006

P1433

American Journal of Cardiology

P1476

Early detection and prediction of cardiotoxicity in chemotherapy-treated patients

@en

P2093

Bonnie Ky

http://www.w3.org/2001/XMLSchema#string

Elkan F Halpern

http://www.w3.org/2001/XMLSchema#string

Heloisa Sawaya

http://www.w3.org/2001/XMLSchema#string

Igal A Sebag

http://www.w3.org/2001/XMLSchema#string

Irene Kuter

http://www.w3.org/2001/XMLSchema#string

Jonathan Passeri

http://www.w3.org/2001/XMLSchema#string

Joseph R Carver

http://www.w3.org/2001/XMLSchema#string

Juan Carlos Plana

http://www.w3.org/2001/XMLSchema#string

Marielle Scherrer-Crosbie

http://www.w3.org/2001/XMLSchema#string

Michael H Picard

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy.

Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective study

Minimizing cardiotoxicity while optimizing treatment efficacy with trastuzumab: review and expert recommendations.

Response and cardiac toxicity of trastuzumab given in conjunction with weekly paclitaxel after doxorubicin/cyclophosphamide.

Tissue Doppler imaging predicts left ventricular dysfunction and mortality in a murine model of cardiac injury.

Strain rate imaging detects early cardiac effects of pegylated liposomal Doxorubicin as adjuvant therapy in elderly patients with breast cancer.

Use of myocardial deformation imaging to detect preclinical myocardial dysfunction before conventional measures in patients undergoing breast cancer treatment with trastuzumab.

Myocardial strain measurement with 2-dimensional speckle-tracking echocardiography: definition of normal range.

Cardiotoxicity of anthracycline in young breast cancer female patients: the possibility of detection of early cardiotoxicity by TDI.

Acute cardiac functional and morphological changes after Anthracycline infusions in children.

P304

1375-1380

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AMJCARD.2011.01.006

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P50

James L Januzzi

P577

2011-03-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21371685

http://www.w3.org/2001/XMLSchema#string

P921

P932

3703314

http://www.w3.org/2001/XMLSchema#string